| Dr Joseph Roarty, MD | |
|
5 Executive Cir, Savannah, GA 31406-3345 | |
| (912) 355-2400 | |
| Not Available |
| Full Name | Dr Joseph Roarty |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 19 Years |
| Location | 5 Executive Cir, Savannah, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801004155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 061648 (Georgia) | Secondary |
| 207P00000X | Emergency Medicine | 061648 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Medical Center | Toms river, NJ | Hospital |
| Monmouth Medical Center | Long branch, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urgent Care Of Berwick Llc | 4789900051 | 10 |
| Rwjbh Emergency Medicine Associates, Llc | 0941612840 | 613 |
News Archive
Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study in the December 12 issue of JAMA.
Higher rates of alcohol use and drinking consequences are found among Hispanic American adolescents and adults who are more "Americanized," according to a new study authored by Southern Methodist University professor Priscilla Lui and her colleague, Byron Zamboanga, at Smith College.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
Haematoma expansion, disability and death are common among patients who have intracerebral haemorrhage while taking novel oral anticoagulants, a study in JAMA Neurology shows.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
› Verified 1 days ago
| Entity Name | Urgent Care Of Berwick Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083018485 PECOS PAC ID: 4789900051 Enrollment ID: O20150303002480 |
News Archive
Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study in the December 12 issue of JAMA.
Higher rates of alcohol use and drinking consequences are found among Hispanic American adolescents and adults who are more "Americanized," according to a new study authored by Southern Methodist University professor Priscilla Lui and her colleague, Byron Zamboanga, at Smith College.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
Haematoma expansion, disability and death are common among patients who have intracerebral haemorrhage while taking novel oral anticoagulants, a study in JAMA Neurology shows.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
› Verified 1 days ago
| Entity Name | Skidaway Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164188413 PECOS PAC ID: 3173915527 Enrollment ID: O20220118000620 |
News Archive
Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study in the December 12 issue of JAMA.
Higher rates of alcohol use and drinking consequences are found among Hispanic American adolescents and adults who are more "Americanized," according to a new study authored by Southern Methodist University professor Priscilla Lui and her colleague, Byron Zamboanga, at Smith College.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
Haematoma expansion, disability and death are common among patients who have intracerebral haemorrhage while taking novel oral anticoagulants, a study in JAMA Neurology shows.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Roarty, MD 115 Greenview Dr, Savannah, GA 31405-1073 Ph: (201) 240-6107 | Dr Joseph Roarty, MD 5 Executive Cir, Savannah, GA 31406-3345 Ph: (912) 355-2400 |
News Archive
Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study in the December 12 issue of JAMA.
Higher rates of alcohol use and drinking consequences are found among Hispanic American adolescents and adults who are more "Americanized," according to a new study authored by Southern Methodist University professor Priscilla Lui and her colleague, Byron Zamboanga, at Smith College.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
Haematoma expansion, disability and death are common among patients who have intracerebral haemorrhage while taking novel oral anticoagulants, a study in JAMA Neurology shows.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
› Verified 1 days ago
Bradley Post, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 912-350-3849 | |
Eriny Hanna, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 615-482-7119 | |
Donald Paul Taylor, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4700 Waters Ave, Emergency Department, Savannah, GA 31404 Phone: 912-350-3849 | |
Matthew Joseph Weis, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5353 Reynolds St, Savannah, GA 31405 Phone: 912-819-6000 | |
Ruth Pannell Crider, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5 Executive Cir, Savannah, GA 31406 Phone: 912-355-2400 Fax: 912-355-5324 | |
Robert Risch, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 912-350-3849 | |
Mary Kay Ross, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 912-350-3849 |